![ProAct 360 offers improved returns on investment and its value proposition goes beyond the product itself. (Image source: Adobe Stock)](/images/jch-optimize/ng/images_AdobeStock__265681466.webp)
ProAct 360 offers improved returns on investment and its value proposition goes beyond the product itself. (Image source: Adobe Stock)
The DSM|Novozymes Feed Enzymes alliance has announced the commercial release of its second-generation protease, ProAct 360